tiprankstipranks
Grace Therapeutics (GRCE)
NASDAQ:GRCE
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Stock News & Sentiment

1,143 Followers
Grace Therapeutics Reports Steady Progress and Financials
Premium
Company Announcements
Grace Therapeutics Reports Steady Progress and Financials
6d ago
Acasti Pharma, Inc. ( ($GRCE) ) has released its Q2 earnings. Here is a breakdown of the information Acasti Pharma, Inc. presented to its investors. Grace Therapeutics, Inc., formerly known ...Read more
ACST Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ACST Earnings Report this Week: Is It a Buy, Ahead of Earnings?
18d ago

News Score - Last 7 Days

Neutral
GRCE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average64%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GRCE’s Media Buzz Sentiment?
1 articles about GRCE were published this week. In an average week, 1 articles are published.
    What is GRCE’s weekly average amount of articles?
    In an average week, 1 articles about GRCE are published.
      What is GRCE’s News Sentiment?
      100% of articles about GRCE were positive this week, compared to its sector average of 64%.
        Healthcare Stocks that are Trending in the News
        SRRKScholar Rock Holding
        REPLReplimune Group
        NVCRNovoCure
        BBIOBridgeBio Pharma
        AMGNAmgen
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis